Yahoo Web Search

Search results

    • Clene (NASDAQ: CLNN) Presents Extended Survival Data at 2024 ENCALS Meeting

      Digital Journal· 5 days ago

      ...Clene (NASDAQ: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, presented...

    • Ambev (NYSE:ABEV) Stock Rating Lowered by StockNews.com

      ETF DAILY NEWS· 12 hours ago

      StockNews.com downgraded shares of Ambev (NYSE:ABEV – Free Report) from a strong-buy rating to a buy rating in a report published on Monday. A number of other analysts have also recently weighed ...